Company Overview

Development Stage

About the Company

Pfizer Inc. was founded in 1849, with a history of over 160 years. Headquartered in New York, USA, it is currently the world's largest research-based biopharmaceutical company. Pfizer is committed to applying innovative science and technology as well as global resources to improve health and well-being at every stage of life.

Our goal is to "continuously innovate to bring patients medicines that can significantly improve their health". Our mission is to "become an outstanding innovative biopharmaceutical company".

In 2012, Pfizer's total annual revenue was $59 billion, with R&D investment of $7.8 billion. Pfizer has over 90,000 employees worldwide, 59 production bases, and operates in more than 150 countries and regions. In the 2012 Fortune Global 500 ranking, Pfizer ranked 126th.

Currently, Pfizer's products cover a wide range of therapeutic and health fields, including chemical drugs, biologics, vaccines, consumer healthcare products, and animal health products for human, animal, and consumer health. Meanwhile, its outstanding R&D and production capabilities hold a leading position.

In the discovery, development, and production of human and animal pharmaceuticals, Pfizer has always been committed to adhering to strict quality, safety, and value standards. Every day, Pfizer employees around the world work to promote local healthcare development and explore prevention and treatment solutions for the most challenging diseases today.

Pfizer also collaborates with healthcare professionals, governments, and communities worldwide to support people's access to more reliable and affordable healthcare services. This is consistent with Pfizer's responsibility as a leading biopharmaceutical company. For more than 160 years, Pfizer has strived to provide better and higher-quality services to people.

Pfizer Biopharmaceutical has launched more than 50 innovative drugs in China, covering therapeutic areas such as cardiovascular and metabolic diseases, anti-infectives, central nervous system, anti-inflammatory and analgesic, oncology, urology, vaccines, and more. Among them, products like Lipitor®, Norvasc®, Viagra®, Sulperazon®, Zithromax®, Prevenar®, and Sutent® hold leading market positions. To enable Chinese patients to timely receive advanced drug treatments in sync with the global standard, Pfizer will further accelerate and intensify the introduction and launch of new drugs in China in the future.

Pfizer Consumer Healthcare's products such as Centrum®, Caltrate®, and Advil® are household names in the Chinese market and are favored by consumers for their excellent quality. Additionally, Pfizer's Zoetis animal health business provides various leading animal vaccines and pharmaceuticals for China's animal health market.

At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety, and value in the discovery, development, and manufacturing of medicines for people and animals. Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world's best-known healthcare products such as Centrum. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our time. Consistent with our responsibility as the world's leading biopharmaceutical company, we also collaborate with healthcare providers, governments, and local communities to support expanded access to reliable, affordable healthcare around the world. For more than 160 years, Pfizer has worked to make a difference for all who rely on us.

Resume collection email: @.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (2 open positions)

Manage
Note: How fast is hiring at HuiZhi Pharmaceutical (Dalian) Co., Ltd. growing? 2025: 39 openings (up 129%), 2024: 17 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

— What Are the Salaries Like? (38 records)

Manage
salary range: 3K - 20K, 73.7% of roles pay ¥8-15K
Note: salary statistics are based on 38 salary records from the past year and depend on the job sample. For reference only.
How is the salary at HuiZhi Pharmaceutical (Dalian) Co., Ltd.?73.7% of positions earn 8-15K, Fresh graduate salary: ¥3.8K。Dalian salary ranking: #374,销售类 average salary ¥12.3K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)
Are salaries high at HuiZhi Pharmaceutical (Dalian) Co., Ltd.? We provide: 医药代表,销售,信息,实习生,临床,学术专员,患教专员,药学,qc,react,供应链,分析,前端,开发工程师,零售. Click to view detailed salary analysis by job.

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Job Category

  • 销售类
    76.3% of total 76.3%
  • 医疗卫生/美容保健类
    23.7% of total 23.7%
  • 计算机/网络/技术类
    13.2% of total 13.2%
  • 在校学生类
    7.9% of total 7.9%

Education

  • 大专
    50% of total 50%
  • 本科
    42.1% of total 42.1%
  • 不限
    7.9% of total 7.9%

Experience

  • 不限
    50% of total 50%
  • 1-3年
    31.6% of total 31.6%
  • 应届生
    7.9% of total 7.9%
  • 3-5年
    5.3% of total 5.3%
View Detailed Analysis

What does HuiZhi Pharmaceutical (Dalian) Co., Ltd. require? Who is HuiZhi Pharmaceutical (Dalian) Co., Ltd. hiring? recruitment: 销售类占比最多占76.3%,其次是医疗卫生/美容保健类占23.7%. What education can get in at ? 大专占比最多占50%,其次是本科占42.1%. Work experience required at ? 不限占比最多占50%,其次是1-3年占31.6%. Where are the job locations at ? 北京占比最多占31.6%,其次是上海占13.2%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 8,040万(美元)
Legal Representative: 孟昱
Date Established:
Credit Code: 912102006048147187
Registered Address: 辽宁省大连经济技术开发区大庆路22号

Partners & Suppliers

向晖致制药(大连)有限公司提供原料药 Source
供应商 原料药
通过国药控股分销晖致制药(大连)有限公司生产的药品 Source
合作客户 药品流通

People who follow this company also follow

Competitors (Similar Companies)

医药 饲料添加剂 生物化学 分离纯化
生物制药 疫苗 疫苗生产 生物疫苗
半导体存储 工厂 晶圆 半导体
“Helping people around the world live healthier at every stage of life”
核酸 生物制品 生物科技/生物工程 生命科学
制药/药业 医药 生产 环境管理
集装箱 集装箱船 VLCC油轮 矿砂运输船
生物制品 疫苗生产 人用疫苗 流感疫苗
抗生素 生物制剂 中成药 制药/药业
聚酯/PET 炼化 PTA 流化床
“Top 15 in China's Pump Industry”
工业自动化 智能机器人 自动化 智能生产线
医药 化妆品 试剂 细胞培养
压力容器 锅炉 中央空调 制冷
机械制造 发动机 汽车发动机 汽车装配线

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates